Ignite Creation Date:
2024-05-06 @ 2:58 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04482985
Status:
UNKNOWN
Last Update Posted:
2020-07-23
First Post:
2020-07-19
Brief Title:
Meclizine Plasma Levels in Responders and Non-responders
Sponsor:
Medical Corps Israel Defense Force
Organization:
Medical Corps Israel Defense Force
Study Overview
Official Title:
Meclizine Plasma Levels in Responders and Non-responders
Status:
UNKNOWN
Status Verified Date:
2020-07
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Motion sickness is a debilitating condition that can effect many crew members Meclizine has long been known as an effective anti motion sickness drug The response to the drug is variable - some are responders while others are resistant to the drug The aim of the present study is to examine whether there is a correlation between meclizine plasma levels and clinical response
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None